LAWRENCE — The University of Kansas School of Pharmacy is No. 4 in the country in National Institutes of Health funding, marking the 23rd consecutive year the school has been in the top 10.
The School of Pharmacy earned more than $11 million in NIH research funding in 2017 fiscal year.
The NIH is a primary source of federal funding for pharmacy schools. Which institutes receive that funding is a key indicator of the productivity and quality of a school’s faculty, according to KU School of Pharmacy Dean Ken Audus. Projects funded by these increasingly competitive grants drive advances in pharmaceutical research and improve the lives of people in Kansas, the United States and throughout the world.
“We’re proud to remain in the top 10, a position we have held for more than two decades. We’re even more proud of the work done by our faculty,” Audus said. “Federal funding is harder to come by each year, yet our researchers continue to secure the funding they need to do life-changing work and prove time and again that they are among the world’s elite.”
According to a report from the Blue Ridge Institute for Medical Research, 74 schools of pharmacy received NIH funding in 2017, and the average grant total per school was $4.1 million.
KU is the only Big 12 institution in the top 10.